Pharma & Bio
Manufacturing
'Expectations for Technology Transfer Grow'—B.A. Pharmtech Rises... JLK, Inc. and Raphas Co., Ltd. Also Up [Bio Spotlight]
On the 18th, the domestic pharmaceutical and biotech stock market saw notable gains in the share prices of BL Pharmtech(065170), JLK, Inc.(322510), and Raphas Co., Ltd.(214260). In particular, BL Phar…
Technology
Kim Kyu-tae, President of Pharos iBio Co., Ltd.: "Pushing Ahead with U.S. Clinical Trials for Solid Tumor Treatment... Currently Discussing Combination Therapy Trials with Big Pharma"
The business focus of the artificial intelligence (AI)-driven new drug development industry is evolving toward the clinical stage through technology transfers or joint development. A recent technology…
Technology
Novartis Dominates the Oral Weight-Loss Drug Market… Lilly’s “Foundayo” Faces a Tough Road in the Race to Catch Up
In the oral glucagon-like peptide-1 (GLP-1) market—considered the next battleground in the global obesity treatment market—Novo Nordisk is currently dominating the field. Eli Lilly is seeking a turnar…
Business·Industry
"Leading with Fine Chemicals, Moving from Active Pharmaceutical Ingredients to Advanced Materials"... Is the Transformation of Pamicell and Kukjeon Justified? [Dragon vs. Tiger: K-Bio]
Pharmaceutical and biotech companies are expanding their reach into markets for advanced industrial materials—such as artificial intelligence (AI), semiconductors, and electronic materials—by leveragi…
Technology
CoreLineSoft Sets Another Record for German Contracts in May… “Entering a Phase of Recurring Revenue Driven by National Screening Programs”
#CoreLineSoft is rapidly expanding its contracts with local hospitals following the launch of Germany’s national lung cancer screening program. CoreLineSoft, which signed 10 new hospital contracts in …
Lifestyle
'A Comeback for a Treatment Once Thought to Have Failed'… GoBioLab Identifies Key Switch for Psoriasis
“Psoriasis may appear to be a skin condition, but it is actually a systemic inflammatory disease caused by an immune system disorder. We have confirmed that regulating gut microbiota can reduce skin i…
Lifestyle
AriBio and FirstBio Join Lilly’s AI Ecosystem... What Are the Real Benefits?
Korean biotech companies AriBio and First BioTherapeutics have successively joined TuneLab, the artificial intelligence (AI)-based new drug development platform of global pharmaceutical company Eli Li…
Business·Industry
'Armed with 2400억 in Funding,' Olix Accelerates Development of New Short-Interference RNA Drugs for Conditions Other Than Liver Disease
A chill is sweeping through the KOSDAQ biotech market. Even companies that were once highlighted as leading new drug developers have faced stock price corrections. In the stock market, there are conce…
KOSDAQ
Biotech Sector Rises, Led by Hair Loss Stocks… JW New Drug Rises; D&D Pharmatech, Partnering with LG, Also Gains Attention [Bio Spotlight]
On the 17th, the domestic pharmaceutical and biotech sector saw related stocks rally across the board following news that the government is considering expanding health insurance coverage for hair los…
KOSDAQ
Hair-Loss Stocks Lead Biotech Rally...JW Shinyak Hits Daily Limit Up, D&D Pharmatech Gains on LG Partnership [K-Bio Pulse]
South Korea’s pharmaceutical and biotechnology sector saw broad gains on Aug. 17 as stocks related to hair loss treatments surged following news that the government is reviewing the expansion of Natio…